Table 4.
Palliative care concerns | Global quality of life QLQ-C30 | EQ5D Index | |||||||
---|---|---|---|---|---|---|---|---|---|
Independent variables | Coefficient | Lower CI | Upper CI | Coefficient | Lower CI | Upper CI | Coefficient | Lower CI | Upper CI |
(Constant) | 20.639** | 14.189 | 27.089 | 105.788** | 100.986 | 110.589 | 1.168** | 1.093 | 1.242 |
General symptom level | 1.439** | 1.136 | 1.741 | – | – | – | – | – | – |
Pain | 0.046* | 0.016 | 0.076 | −2.572* | −4.168 | −0.975 | −0.100** | −0.129 | −0.071 |
Weakness/lack of energy | – | – | – | −5.741** | −7.395 | −4.086 | – | – | – |
Drowsiness | – | – | – | – | – | – | 0.032 | 0.000 | 0.064 |
Dry mouth | 1.395** | 0.558 | 2.233 | – | – | – | – | – | – |
HADS Anxiety | 1.100** | 0.891 | 1.308 | −2.519* | −4.091 | −0.947 | – | – | – |
HADS Depression | – | – | – | −3.749** | −5.446 | −2.052 | −0.075** | −0.102 | −0.048 |
Age | −0.136** | −0.204 | −0.069 | – | – | – | – | – | – |
Being in the stable/plateau phasea | −2.693** | −4.096 | −1.290 | 4.804** | 2.127 | 7.482 | – | – | – |
ECOG performance status 2b | – | – | – | −3.654 | −7.449 | 0.141 | – | – | – |
ECOG performance status 3/4 – limited self-care or completely disabledc | – | – | – | – | – | – | −0.159** | −0.248 | −0.070 |
Physical function/Poor mobility | −0.138** | −0.174 | −0.101 | −5.085** | −6.610 | −3.560 | −0.082** | −0.110 | −0.054 |
Adjusted R2 | 0.879 | 0.514 | 0.584 | ||||||
F, P | F = 192.205 | P < 0.001 | F = 85.522 | P < 0.001 | F = 61.924 | P < 0.001 |
ECOG Eastern Cooperative Oncology Group performance status, CI confidence interval, EQ5D EuroQol-5D-3L, HADS Hospital Anxiety and Depression Scale, MyPOS Myeloma Patient Outcome Scale
aReference group is patients being unstable, i.e. newly diagnosed or having relapsed, progressive or palliative disease or being in a treatment-interval
bReference group is ECOG performance status of 0
cReference group is ECOG performance status of 0
*p < 0.05
**p < 0.001